Who are Bufei Yishen granule's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Placebo of Gastrodia and Uncaria granule, Fuzheng Huayu Tablets.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bufei-yishen-granule.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Bufei Yishen granule — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bufei Yishen granule (Bufei Yishen granule) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal medicine / Traditional Chinese Medicine. Area: Respiratory / Renal.

phase 3 Herbal medicine / Traditional Chinese Medicine Respiratory / Renal Small molecule Live · refreshed every 30 min

Target snapshot

Bufei Yishen granule (Bufei Yishen granule) — Henan University of Traditional Chinese Medicine. Bufei Yishen granule is a traditional Chinese medicine formulation that aims to tonify lung and kidney function to improve respiratory and renal health.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Bufei Yishen granule TARGET	Bufei Yishen granule	Henan University of Traditional Chinese Medicine	phase 3	Herbal medicine / Traditional Chinese Medicine
Placebo of Gastrodia and Uncaria granule	Placebo of Gastrodia and Uncaria granule	Shanghai Institute of Hypertension	marketed	Herbal medicine / Traditional Chinese medicine
Fuzheng Huayu Tablets	Fuzheng Huayu Tablets	Shanghai University of Traditional Chinese Medicine	marketed	Herbal medicine / Traditional Chinese Medicine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal medicine / Traditional Chinese Medicine class)

Henan University of Traditional Chinese Medicine · 1 drug in this class
Shanghai University of Traditional Chinese Medicine · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bufei Yishen granule — Competitive Intelligence Brief. https://druglandscape.com/ci/bufei-yishen-granule. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing